Omega Medical Research   Report issue

For profit Phase 2
Founded: Warwick RI United States (1993)

Organization Overview

First Clinical Trial
2007
NCT00419263
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Omega Medical Research, Warwick, RI 02886

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Herpes Labialis (Phase 2)

Influenza, Human (Phase 2)

Intermittent Claudication (Phase 2)

Peripheral Arterial Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4